In summary, these findings demonstrate that the “smart” exosome targeting delivery strategy of aCD20@ExoCTX/siPDK4 not only kills tumors but also enhances the tumor immune microenvironment by promoting immunogenic cell death, maturing DCs, activating CD8+ T cells, and suppressing Treg cells. This evidence concerns the gene CD8A and neoplasm.